Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06324929 · ClinicalTrials.gov registry record · NA
Optimizing a Digital AEP Risk Intervention With Native Women and Communities
A NA study of Sexual Behavior and Alcohol Use, Unspecified, sponsored by University of Virginia.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT06324929: Recruiting NA study of Sexual Behavior and Alcohol Use, Unspecified, sponsored by University of Virginia.
NCT06324929 is a NA study of Sexual Behavior and Alcohol Use, Unspecified that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 350 participants, below the 3,409-participant average among 20 other Sexual Behavior trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06324929, a NA study of Sexual Behavior and Alcohol Use, Unspecified, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of Aim 1 of the study is to gather quantitative and qualitative information to inform the development of a digital app tailored for Native American women to help them avoid a pregnancy affected by alcohol. In Aim 2, we will Pilot test 5 new candidate components tailored to Native women at risk of AEP
Primary Outcome
Defined as binge drinking, and/or drinking over daily risk levels. Unit of measure: Rate of risky drinking Measurement tool: TLFB (timeline follow-back) of alcohol use and contraception use during sex Outcomes 1 and 2 are combined to define alcohol-exposed pregnancy risk.
Conditions Studied
Interventions
- BEHAVIORAL CARRII Native Rapid Pilot Testing
Study Locations (1)
Virginia
- University of Virginia Fontaine Research Park - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-05-16 |
| Est. Completion | 2025-10-17 |
| Phase | NA |
What NCT06324929 shows while recruiting
NCT06324929 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 3,409-participant average among 20 other Sexual Behavior trials with a reported enrollment target (90% lower).
The record links to 5 conditions, with Sexual Behavior appearing as the primary indexed condition, and to 1 intervention - of which CARRII Native Rapid Pilot Testing is the first listed.
NCT06324929 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06324929 about?
NCT06324929 is a clinical study titled "Optimizing a Digital AEP Risk Intervention With Native Women and Communities". The purpose of Aim 1 of the study is to gather quantitative and qualitative information to inform the development of a digital app tailored for Native American women to help them avoid a pregnancy affected by alcohol. In Aim 2, we will Pilot test 5 new candidate components tailored to Native women a...
What is the current status of trial NCT06324929?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-05-16. Estimated completion is 2025-10-17.
What conditions does trial NCT06324929 study?
This clinical trial studies the following conditions: Sexual Behavior, Alcohol Use, Unspecified, Unplanned Pregnancy, Alcohol Exposed Pregnancy, Contraception Use.
What interventions are being tested in trial NCT06324929?
The interventions under investigation include: CARRII Native Rapid Pilot Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT06324929?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06324929 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexual Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06324929's enrollment target sits among peer trials
350 10th of 20 higher than 11 of 20 other Sexual Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sexual Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)
RECRUITING · NA
-
Rigorous Evaluation of Let's Talk Birth Control
RECRUITING · NA
-
Young Adult Education on Alcohol & Health
RECRUITING · NA
-
Journey of Transformation Curriculum for Native American Youth
RECRUITING · NA
-
IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)
RECRUITING · NA
-
Alcohol & Men's Sexual Risk Behaviors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI